Search results
Results from the WOW.Com Content Network
Staphylococcus intermedius is a Gram-positive, catalase positive member of the bacterial genus Staphylococcus consisting of clustered cocci. Strains of this species were originally isolated from the anterior nares of pigeons, dogs, cats, mink, and horses. Many of the isolated strains show coagulase activity. [2]
Staphylococcus pseudintermedius was first identified as a novel species in 2005 using 16S rRNA gene sequencing of the tRNA intergenic length polymorphisms of the AJ780976 gene loci. [15] [16] [17] Differing strains of S. pseudintermedius, LMG 22219 - LMG 22222, have been identified in various species: cat, horse, dog, and parrot, respectively. [15]
Staphylococcus cornubiensis is a species of Gram-positive cocci in the Staphylococcus intermedius Group (SIG): [1] a group of genetically and phenotypically similar bacterial species that were previously identified as S. intermedius. [2] [3] The bacterium was first isolated from a human skin infection in Cornwall, United Kingdom. [1]
Staphylococcus is a genus of Gram-positive bacteria in the family Staphylococcaceae from the order Bacillales. Under the microscope, they appear spherical , and form in grape-like clusters. Staphylococcus species are facultative anaerobic organisms (capable of growth both aerobically and anaerobically).
Although most are unaffected by rash, where noticed a broad rash can be concentrated to the back of the neck, scapular (shoulder blade) and surrounding areas, and/or the lower abdomen and surrounding areas. Secondary infection with Staphylococcus intermedius is common. Signs include itchiness, "elevated grooming", and visible spots of fur-loss.
However, staph infections are still prominent and a cause for concern among healthcare professionals, especially new antibiotic-resistant strains. In the U.S., the incidence of staph infection is around 38.2 to 45.7 per 100,000 person-years, whereas other First World countries have an average incidence rate of 10 to 30 per 100,000 person-years.
Today's NYT Connections puzzle for Friday, January 17, 2025The New York Times
Cefovecin is an antibiotic of the cephalosporin class, licensed for the treatment of skin infections in cats and dogs. It is marketed by Zoetis under the trade name Convenia. It is used to treat skin infections caused by Pasteurella multocida in cats, and Staphylococcus intermedius and Streptococcus canis in dogs. The advantage of using a long ...